Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jul 31;12(8):758. doi: 10.1038/s41419-021-04040-9

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2021

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Fig. 1 — A The differentially expressed F-box proteins (FBPs) in ovarian cancer were identified from TCGA database by employing a strict criterion (|log2FC| > 1, p < 0.01) base on an online analysis website GEPIA2 (http://gepia2.cancer-pku.cn/). B FBXO16 mRNA expression of tumor and normal tissues in TCGA ovarian cancer dataset. C The mRNA expression of FBXO16 was highly expressed in most ovarian cell lines in the Cancer Cell Line Encyclopedia (CCLE) database (https://portals.broadinstitute.org/ccle). D The overall survival (OS) curve of FBXO16 is plotted for all ovarian cancer patients in the Kaplan–Meier Plotter database (http://kmplot.com/). E The post-progression survival (PPS) curve of FBXO16 is plotted for all ovarian cancer patients in the Kaplan-Meier Plotter database. F The overall survival (OS) curve of FBXO16 is plotted for stage 2 and stage 3 ovarian cancer patients in the Kaplan–Meier Plotter database.